A mixed approach for proving non-inferiority in clinical trials with binary endpoints
From MaRDI portal
Recommendations
- Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes
- Assessing additional benefit in noninferiority trials
- The likelihood ratio test for order restricted hypotheses in non-inferiority trials.
- Re-formulating non-inferiority trials as superiority trials: the case of binary outcomes
- Designs of superiority and noninferiority trials for binary responses are noninterchangeable
Cited in
(10)- Non-inferiority testing for risk ratio, odds ratio and number needed to treat in three-arm trial
- Assessing additional benefit in noninferiority trials
- A COMPARISON OF THE IMPRECISE BETA CLASS, THE RANDOMIZED PLAY‐THE‐WINNER RULE AND THE TRIANGULAR TEST FOR CLINICAL TRIALS WITH BINARY RESPONSES
- Correct and logical inference on efficacy in subgroups and their mixture for binary outcomes
- Selection of composite binary endpoints in clinical trials
- A Regulatory Perspective on Choice of Margin and Statistical Inference Issue in Non‐inferiority Trials
- Re-formulating non-inferiority trials as superiority trials: the case of binary outcomes
- Notes on odds ratio estimation for a randomized clinical trial with noncompliance and missing outcomes
- Estimating and Testing Treatment Effects on Two Binary Endpoints and Association Between Endpoints in Clinical Trials
- Interval estimation of odds ratio in a stratified randomized clinical trial with noncompliance
This page was built for publication: A mixed approach for proving non-inferiority in clinical trials with binary endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5123040)
